Ablation of manifest septal accessory pathways: a single-center experience.


Journal

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing
ISSN: 1572-8595
Titre abrégé: J Interv Card Electrophysiol
Pays: Netherlands
ID NLM: 9708966

Informations de publication

Date de publication:
Aug 2021
Historique:
received: 09 02 2020
accepted: 05 07 2020
pubmed: 16 7 2020
medline: 19 8 2021
entrez: 16 7 2020
Statut: ppublish

Résumé

Ablation of septal accessory pathways (SAPs) is associated with an increased risk of heart block. Data on outcomes of SAP ablation in adults are limited. To describe outcomes of SAP ablation in our center. Patients with Wolff-Parkinson-White syndrome (WPW) undergoing an EP study at our center between January 2008 and August 2019 were identified from our institutional database. Location of the pathway was noted as anteroseptal (AS), midseptal (MS), or posteroseptal (PS). Outcomes of the ablation including success, complication rates, and recurrences were also recorded. Thirty-three patients with SAP underwent 35 EP studies: AS (n = 13), MS (n = 5), and PS (n = 15). Thirty pathways were targeted for ablation, two of which required a 2nd procedure resulting in 32 attempts at ablation in 30 patients. In the remaining 3 patients, SAP did not have malignant features and were not targeted for ablation. Single-procedure success rate was 28/30 (93.33%): 9/10 AS, 5/5 MS, and 14/15 PS ablations. One AS pathway was successfully ablated during a 2nd procedure. Two complications were observed: 1 pericardial effusion in a patient who underwent epicardial mapping and ablation of both PS and right free wall APs. Additionally, transient 2:1 AV block occurred during an MS pathway ablation that recovered during follow-up and did not require permanent pacing procedure. In this single-center experience, ablation of manifest SAP was associated with high success rates and low complication rates. No instances of permanent heart block requiring pacing occurred.

Sections du résumé

BACKGROUND BACKGROUND
Ablation of septal accessory pathways (SAPs) is associated with an increased risk of heart block. Data on outcomes of SAP ablation in adults are limited.
OBJECTIVES OBJECTIVE
To describe outcomes of SAP ablation in our center.
METHODS METHODS
Patients with Wolff-Parkinson-White syndrome (WPW) undergoing an EP study at our center between January 2008 and August 2019 were identified from our institutional database. Location of the pathway was noted as anteroseptal (AS), midseptal (MS), or posteroseptal (PS). Outcomes of the ablation including success, complication rates, and recurrences were also recorded.
RESULTS RESULTS
Thirty-three patients with SAP underwent 35 EP studies: AS (n = 13), MS (n = 5), and PS (n = 15). Thirty pathways were targeted for ablation, two of which required a 2nd procedure resulting in 32 attempts at ablation in 30 patients. In the remaining 3 patients, SAP did not have malignant features and were not targeted for ablation. Single-procedure success rate was 28/30 (93.33%): 9/10 AS, 5/5 MS, and 14/15 PS ablations. One AS pathway was successfully ablated during a 2nd procedure. Two complications were observed: 1 pericardial effusion in a patient who underwent epicardial mapping and ablation of both PS and right free wall APs. Additionally, transient 2:1 AV block occurred during an MS pathway ablation that recovered during follow-up and did not require permanent pacing procedure.
CONCLUSION CONCLUSIONS
In this single-center experience, ablation of manifest SAP was associated with high success rates and low complication rates. No instances of permanent heart block requiring pacing occurred.

Identifiants

pubmed: 32666409
doi: 10.1007/s10840-020-00823-w
pii: 10.1007/s10840-020-00823-w
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

349-355

Informations de copyright

© 2020. Springer Science+Business Media, LLC, part of Springer Nature.

Références

Haghjoo M, Kharazi A, Fazelifar AF, Alizadeh A, Emkanjoo Z, Sadr-Ameli MA. Electrocardiographic and electrophysiologic characteristics of anteroseptal, midseptal, and posteroseptal accessory pathways. Heart Rhythm. 2007;4(11):1411–9.
doi: 10.1016/j.hrthm.2007.07.009
Lin JL, Huang SK, Lai LP, Cheng TF, Tseng YZ, Lien WP. Radiofrequency catheter ablation of septal accessory pathways within the triangle of Koch: importance of energy titration testing other than the local electrogram characteristics for identifying the successful target site. Pacing Clin Electrophysiol. 1998;21(10):1909–17.
doi: 10.1111/j.1540-8159.1998.tb00010.x
Schaffer MS, Silka MJ, Ross BA, Kugler JD. Inadvertent atrioventricular block during radiofrequency catheter ablation. Results of the pediatric radiofrequency ablation registry. Pediatric electrophysiology society. Circulation. 1996;94(12):3214–3220.
Xie B, Heald SC, Bashir Y, Camm AJ, Ward DE. Radiofrequency catheter ablation of septal accessory atrioventricular pathways. Br Heart J. 1994;72(3):281–4.
doi: 10.1136/hrt.72.3.281
Van Hare GF, Javitz H, Carmelli D, et al. Prospective assessment after pediatric cardiac ablation: demographics, medical profiles, and initial outcomes. J Cardiovasc Electrophysiol. 2004;15(7):759–70.
doi: 10.1046/j.1540-8167.2004.03645.x
Macedo PG, Patel SM, Bisco SE, Asirvatham SJ. Septal accessory pathway: anatomy, causes for difficulty, and an approach to ablation. Indian Pacing Electrophysiol J. 2010;10(7):292–309.
pubmed: 20680108 pmcid: 2907089
Kuck KH, Schluter M, Geiger M, Siebels J, Duckeck W. Radiofrequency current catheter ablation of accessory atrioventricular pathways. Lancet. 1991;337(8757):1557–61.
doi: 10.1016/0140-6736(91)93258-B
Bar-Cohen Y, Cecchin F, Alexander ME, Berul CI, Triedman JK, Walsh EP. Cryoablation for accessory pathways located near normal conduction tissues or within the coronary venous system in children and young adults. Heart Rhythm. 2006;3(3):253–8.
doi: 10.1016/j.hrthm.2005.11.029
Ergul Y, Tola HT, Kiplapinar N, Akdeniz C, Saygi M, Tuzcu V. Cryoablation of anteroseptal accessory pathways in children with limited fluoroscopy exposure. Pediatr Cardiol. 2013;34(4):802–8.
doi: 10.1007/s00246-012-0536-9
Karadeniz C, Akdeniz C, Turan O, Tuzcu V. Cryoablation of septal accessory pathways in children: midterm results. Pacing Clin Electrophysiol. 2014;37(9):1095–9.
doi: 10.1111/pace.12442
Bravo L, Atienza F, Eidelman G, Ávila P, Pelliza M, Castellanos E, et al. Safety and efficacy of cryoablation vs. radiofrequency ablation of septal accessory pathways: systematic review of the literature and meta-analyses. Europace. 2018;20(8):1334–42.
doi: 10.1093/europace/eux269
Al-Khatib SM, Arshad A, Balk EM, et al. Risk stratification for arrhythmic events in patients with asymptomatic pre-excitation: a systematic review for the 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm. 2016;13(4):e222–37.
doi: 10.1016/j.hrthm.2015.09.017
Pappone C, Vicedomini G, Manguso F, Baldi M, Pappone A, Petretta A, et al. Risk of malignant arrhythmias in initially symptomatic patients with Wolff-Parkinson-White syndrome: results of a prospective long-term electrophysiological follow-up study. Circulation. 2012;125(5):661–8.
doi: 10.1161/CIRCULATIONAHA.111.065722
Mandapati R, Berul CI, Triedman JK, Alexander ME, Walsh EP. Radiofrequency catheter ablation of septal accessory pathways in the pediatric age group. Am J Cardiol. 2003;92(8):947–50.
doi: 10.1016/S0002-9149(03)00975-5
Gaita F, Haissaguerre M, Giustetto C, et al. Safety and efficacy of cryoablation of accessory pathways adjacent to the normal conduction system. J Cardiovasc Electrophysiol. 2003;14(8):825–9.
doi: 10.1046/j.1540-8167.2003.03076.x
Vakil KP, Tholakanahalli VN. Freezing at the his bundle. Indian Pacing Electrophysiol J. 2014;14(6):281–3.
doi: 10.1016/S0972-6292(16)30815-4

Auteurs

Matthew T Brown (MT)

Emory University School of Medicine, Medical office Tower 12th Floor, 550 Peachtree Street NE, Atlanta, GA, 30308, USA.

Soroosh Kiani (S)

Emory University School of Medicine, Medical office Tower 12th Floor, 550 Peachtree Street NE, Atlanta, GA, 30308, USA.

George B Black (GB)

Emory University School of Medicine, Medical office Tower 12th Floor, 550 Peachtree Street NE, Atlanta, GA, 30308, USA.

Marvin L R Lu (MLR)

Emory University School of Medicine, Medical office Tower 12th Floor, 550 Peachtree Street NE, Atlanta, GA, 30308, USA.

Michael Lloyd (M)

Emory University School of Medicine, Medical office Tower 12th Floor, 550 Peachtree Street NE, Atlanta, GA, 30308, USA.

Angel R Leon (AR)

Emory University School of Medicine, Medical office Tower 12th Floor, 550 Peachtree Street NE, Atlanta, GA, 30308, USA.

Anand Shah (A)

Emory University School of Medicine, Medical office Tower 12th Floor, 550 Peachtree Street NE, Atlanta, GA, 30308, USA.

Stacy Westerman (S)

Emory University School of Medicine, Medical office Tower 12th Floor, 550 Peachtree Street NE, Atlanta, GA, 30308, USA.

Faisal M Merchant (FM)

Emory University School of Medicine, Medical office Tower 12th Floor, 550 Peachtree Street NE, Atlanta, GA, 30308, USA.

Mikhael El-Chami (M)

Emory University School of Medicine, Medical office Tower 12th Floor, 550 Peachtree Street NE, Atlanta, GA, 30308, USA. melcham@emory.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH